Retinal microvascularization was altered in patients with type 1 diabetes without clinical signs of diabetic retinopathy, but intensive insulin treatment and optimized diabetes management with continuous glucose-monitoring devices seemed to attenuate the risk of retinal vascular density rarefaction. The gene discussed is INS; the disease is type 1 diabetes mellitus.